PGCX, PanGenex Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients
Dr. Stock Pick (November 18th, 2009) Writes:
Dr Stock Pick HOT News & Alerts!
_________________________________________
FREE Daily Stock Alerts From DrStockPick.com
_________________________________________
Wednesday November 18, 2009
DrStockPick.com Stock Report!
PGCX, Pangenex Corporation, PGCX.PK
**************************************************************
PanGenex Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients
TAMPA, Fla.–(CRWENEWSWIRE -Nov 18, 2009)–PanGenex Corporation (Pink Sheets: PGCX) (“PanGenex” or “the Company”) announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
The Company initiated a 100 patient, placebo based, double blind clinical trial at the CardioVascular Institute of the South. Early results
...Cardiovascular Institute of the South, clinical protocols, dietary supplement, director, Dr Stock Pick, Florida, healthcare practitioners, Investing Lessons, lipid and inflammatory, Mark Turco, Medical Director, MidWest Cardiology Research Foundation, natural product, Pangenex Corporation, Personal Care Products, Peter Fail, principle investigator, retail establishments, Ronald Caputo, Steve Yakubov, Stocks to Watch, Tampa, USD, www.Calgenex.com, www.HeartHealthyWorld.com, www.PanGenex.com


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)



Power3 Medical Products, Inc.
